156 related articles for article (PubMed ID: 16169817)
1. Hematological disorders in Down syndrome: ten-year experience at a Tertiary Care Centre in North India.
Awasthi A; Das R; Varma N; Ahluwalia J; Gupta A; Marwaha RK; Garewal G
Pediatr Hematol Oncol; 2005 Sep; 22(6):507-12. PubMed ID: 16169817
[TBL] [Abstract][Full Text] [Related]
2. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
Zipursky A; Brown EJ; Christensen H; Doyle J
Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
4. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.
Shimada A; Hayashi Y; Ogasawara M; Park MJ; Katoh M; Minakami H; Kitoh T; Kojima S; Kawa K; Kimura H
Leuk Res; 2007 Sep; 31(9):1199-203. PubMed ID: 17055049
[TBL] [Abstract][Full Text] [Related]
6. Hematological disturbances in Down syndrome: single centre experience of thirteen years and review of the literature.
Karakurt N; Uslu İ; Aygün C; Albayrak C
Turk J Pediatr; 2019; 61(5):664-670. PubMed ID: 32104997
[TBL] [Abstract][Full Text] [Related]
7. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
8. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
[TBL] [Abstract][Full Text] [Related]
10. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B
J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165
[TBL] [Abstract][Full Text] [Related]
11. Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic studies in children with Down syndrome and acute leukemia.
Valladares A; Palma-Padilla V; Mejía-Aranguré JM; Guevara-Yánez R; Lerma-Reyes A; Salamanca-Gómez F
Leuk Res; 2005 Nov; 29(11):1241-6. PubMed ID: 16164980
[TBL] [Abstract][Full Text] [Related]
13. MTHFR 677C-->T and 1298A-->C polymorphisms in children with Down syndrome and acute myeloid leukemia in Brazil.
Amorim MR; Zanrosso CW; Magalhães IQ; Pereira SC; Figueiredo A; Emerenciano M; Pinheiro VR; d'Andréa ML; Orioli IM; Koifman S; Pombo-de-Oliveira MS
Pediatr Hematol Oncol; 2008 Dec; 25(8):744-50. PubMed ID: 19065440
[TBL] [Abstract][Full Text] [Related]
14. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
[TBL] [Abstract][Full Text] [Related]
15. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system.
Henry E; Walker D; Wiedmeier SE; Christensen RD
Am J Med Genet A; 2007 Jan; 143A(1):42-50. PubMed ID: 17163522
[TBL] [Abstract][Full Text] [Related]
16. Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: a report from the Children's Oncology Group.
Puumala SE; Ross JA; Olshan AF; Robison LL; Smith FO; Spector LG
Cancer; 2007 Nov; 110(9):2067-74. PubMed ID: 17849462
[TBL] [Abstract][Full Text] [Related]
17. GATA1 mutations in acute leukemia in children with Down syndrome.
Magalhães IQ; Splendore A; Emerenciano M; Figueiredo A; Ferrari I; Pombo-de-Oliveira MS
Cancer Genet Cytogenet; 2006 Apr; 166(2):112-6. PubMed ID: 16631466
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome.
Dixon N; Kishnani PS; Zimmerman S
Am J Med Genet C Semin Med Genet; 2006 Aug; 142C(3):149-57. PubMed ID: 17048354
[TBL] [Abstract][Full Text] [Related]
19. Circulating blasts and associated hematologic disorders in neonates with Down syndrome.
Jackson GL; Sendelbach DM; Rambally B; Manning MD; Engle WD
Am J Perinatol; 2012 Apr; 29(4):259-66. PubMed ID: 21809264
[TBL] [Abstract][Full Text] [Related]
20. [Biventricular hypertrophic non-obstructive cardiomyopathy as a symptom of transient myeloproliferative disorder in a newborn with Down syndrome].
Wacker A; Scheel-Walter HG; Neunhoeffer F
Z Geburtshilfe Neonatol; 2009 Apr; 213(2):64-6. PubMed ID: 19319796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
